Research output per year
Research output per year
Search results
-
2022
Exosomes: Biological Pharmaceutical Nanovectors for Theranostics
Thomas, S. C., Kim, J. W., Pauletti, G. M., Hassett, D. J. & Kotagiri, N., Jan 12 2022, In: Frontiers in Bioengineering and Biotechnology. 9, 808614.Research output: Contribution to journal › Review article › peer-review
Open Access -
2021
Targeting e‐selectin to tackle cancer using uproleselan
Muz, B., Abdelghafer, A., Markovic, M., Yavner, J., Melam, A., Salama, N. N. & Azab, A. K., Jan 2 2021, In: Cancers. 13, 2, p. 1-15 15 p., 335.Research output: Contribution to journal › Review article › peer-review
Open Access -
2020
Pharmacotherapy for Small Fiber Neuropathy
George, T., Kafaie, J., Huang, Z. L. & Profirovic, J., Dec 2020, In: Current Treatment Options in Neurology. 22, 12, 41.Research output: Contribution to journal › Review article › peer-review
-
2018
Comparative effectiveness of lipid-lowering treatments to reduce cardiovascular disease
Suh, D. C., Griggs, S. K., Henderson, E. R., Lee, S. M. & Park, T., Jan 2 2018, In: Expert Review of Pharmacoeconomics and Outcomes Research. 18, 1, p. 51-69 19 p.Research output: Contribution to journal › Review article › peer-review
-
2015
Cost Effectiveness of Monoclonal Antibody Therapy for Rare Diseases: A Systematic Review
Park, T., Griggs, S. K. & Suh, D. C., Aug 13 2015, In: BioDrugs. 29, 4, p. 259-274 16 p.Research output: Contribution to journal › Review article › peer-review
-
The role of P-glycoprotein in drug resistance in multiple myeloma
Abraham, J., Salama, N. N. & Azab, A. K., Jan 1 2015, In: Leukemia and Lymphoma. 56, 1, p. 26-33 8 p.Research output: Contribution to journal › Review article › peer-review